Utilization Patterns of Pulmicort [budesonide] Hydro Fluoroaklane (HFA) Pressurized Metered-Dose Inhaler (pMDI) in Real Life Practice.
Phase of Trial: Phase IV
Latest Information Update: 30 Nov 2010
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 30 Nov 2010 Last checked against ClinicalTrials.gov record.
- 30 Nov 2010 Actual end date changed from (Mar 2009) to (Feb 2009) as reported by ClinicalTrials.gov.
- 06 Mar 2009 Actual patient number (60) reported by ClinicalTrials.gov.